| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503684A Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 06/09/2004 | CN1503678A Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 06/09/2004 | CN1503677A Use of LP 82 to treat hematopoietic disorders |
| 06/09/2004 | CN1503676A Method for treating gout and reducing serum uric a cid |
| 06/09/2004 | CN1503674A Medicines anjd medicinal kits |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1503667A Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 06/09/2004 | CN1503665A Carbamate compounds for sue in preventing or treating anxiety disorders |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502350A Traditional Chinese medicine composition (Fujangtieda liquor) for curing traumatic injury |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152886C Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152873C Novel diphenyl-piperidine derivate |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152866C Benzimidazoles, production thereof and use thereof medicaments |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152857C Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 06/09/2004 | CN1152716C Farnesyl protein transferase inhbitors with internal radiosensitizing |
| 06/09/2004 | CN1152701C Kidney-benefiting and tranquilizing medicine and its prepn |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/09/2004 | CN1152685C Usage of endothelin receptor agonist in preparation of medicine for treating obesity |
| 06/09/2004 | CN1152683C Medicinal composition containing naphthyl compound |
| 06/09/2004 | CN1152682C Usage of histamine receptor antagonists composition in preparation of medicine for treating |
| 06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
| 06/09/2004 | CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent |
| 06/09/2004 | CN1152677C Treatment of spasticity, convulsions by isovaleric acid derivatives CNS |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747144 Collections of compounds |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6747061 N-substituted dithiocarbamates for the treatment of biological disorders |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747049 Oxazole derivatives |
| 06/08/2004 | US6747045 Such as 1-(3-(((3,4-dihydro-2h-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1h)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747035 Antiinflammatory agents; antiallergens |
| 06/08/2004 | US6747034 CRF receptor antagonists and methods relating thereto |
| 06/08/2004 | US6747032 Pyrimidin-4-one compounds |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747030 Cis-6-(3,5-dimethylpiperazin-1-yl)-5-methoxy-1-(2'-methyl-4'-( 5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl)indoline, its hydrochloride salt, or another pharmaceutically acceptable salt thereof; antidepressants |
| 06/08/2004 | US6747028 1,2-substituted benzimidazoles having antiviral activity |
| 06/08/2004 | US6747026 NK-1 receptor active amine oxide prodrugs |
| 06/08/2004 | US6747019 Mixture of estrogen, progesterone; alternating dosage |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746861 Human kinase protein and polynucleotides encoding the same |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/08/2004 | US6746675 Hypoglycemic effects and anti-tumor activity |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046356A1 EXON 1β OF PDGF RECEPTOR α GENE AND UTILIZATION THEREOF |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046222A1 Modified biological substance, process for producing the same, and intermediate |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046161A1 Novel 2’,5’-oligoadenylic acid analogues |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046110A1 Antagonist to melanin-concentrating hormone receptor |
| 06/03/2004 | WO2004046089A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004045644A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND β-BLOCKER |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045635A1 Muslce building preparation |
| 06/03/2004 | WO2004045632A1 Peroxisome proliferator-activated recetor ligand |
| 06/03/2004 | WO2004045603A1 Medicinal composition for treating sudden deafness |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045594A1 Agent for dissolving dental calculi and dental caries |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004035574A3 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003099194A3 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 06/03/2004 | WO2003088761A3 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | WO2003041128A3 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2002070457A8 Inhibitor of monoamine uptake |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106808 Processes for preparing calanolide a and intermediates thereof |
| 06/03/2004 | US20040106803 e.g., 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole; having a tyrosine kinase inhibitory action |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |